DE69518008D1 - Steigerung der kreatin und glykogen konzentration im muskel - Google Patents
Steigerung der kreatin und glykogen konzentration im muskelInfo
- Publication number
- DE69518008D1 DE69518008D1 DE69518008T DE69518008T DE69518008D1 DE 69518008 D1 DE69518008 D1 DE 69518008D1 DE 69518008 T DE69518008 T DE 69518008T DE 69518008 T DE69518008 T DE 69518008T DE 69518008 D1 DE69518008 D1 DE 69518008D1
- Authority
- DE
- Germany
- Prior art keywords
- creatine
- amount
- muscle
- increase
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 title abstract 29
- 229960003624 creatine Drugs 0.000 title abstract 15
- 239000006046 creatine Substances 0.000 title abstract 15
- 210000003205 muscle Anatomy 0.000 title abstract 5
- 230000002394 glycogenic effect Effects 0.000 title 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 8
- 229920002527 Glycogen Polymers 0.000 abstract 5
- 229940096919 glycogen Drugs 0.000 abstract 5
- 230000014759 maintenance of location Effects 0.000 abstract 5
- 239000000203 mixture Substances 0.000 abstract 5
- 102000004877 Insulin Human genes 0.000 abstract 4
- 108090001061 Insulin Proteins 0.000 abstract 4
- 150000001720 carbohydrates Chemical class 0.000 abstract 4
- 229940125396 insulin Drugs 0.000 abstract 4
- 210000002381 plasma Anatomy 0.000 abstract 4
- 241001465754 Metazoa Species 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- -1 creatine carbohydrate Chemical class 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 230000037406 food intake Effects 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9425514.8A GB9425514D0 (en) | 1994-12-17 | 1994-12-17 | Retention of creatine in the body |
| GBGB9517443.9A GB9517443D0 (en) | 1994-12-17 | 1995-08-25 | Increasing creatine and glycogen concentration in muscle |
| PCT/GB1995/002933 WO1996018313A1 (en) | 1994-12-17 | 1995-12-15 | Increasing creatine and glycogen concentration in muscle |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69518008D1 true DE69518008D1 (de) | 2000-08-17 |
| DE69518008T2 DE69518008T2 (de) | 2001-05-17 |
Family
ID=26306194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69518008T Expired - Lifetime DE69518008T2 (de) | 1994-12-17 | 1995-12-15 | Steigerung der kreatin und glykogen konzentration im muskel |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5968900A (de) |
| EP (1) | EP0798971B1 (de) |
| AT (1) | ATE194462T1 (de) |
| AU (1) | AU4185696A (de) |
| CA (1) | CA2208047C (de) |
| DE (1) | DE69518008T2 (de) |
| DK (1) | DK0798971T3 (de) |
| ES (1) | ES2150020T3 (de) |
| GB (1) | GB9517443D0 (de) |
| PT (1) | PT798971E (de) |
| WO (1) | WO1996018313A1 (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7150880B2 (en) * | 1996-05-31 | 2006-12-19 | The Original Creatine Patent Co. Ltd. | Compositions containing creatine and creatinine and a methyl xanthine |
| US6080788A (en) * | 1997-03-27 | 2000-06-27 | Sole; Michael J. | Composition for improvement of cellular nutrition and mitochondrial energetics |
| US6218366B1 (en) | 1998-06-19 | 2001-04-17 | Bioenergy, Inc. | Method for raising the hypoxic threshold |
| US6159942A (en) * | 1998-06-19 | 2000-12-12 | Bioenergy, Inc. | Compositions for increasing energy in vivo |
| US20020119933A1 (en) | 2000-07-28 | 2002-08-29 | Butler Terri L. | Compositions and methods for improving cardiovascular function |
| US6429198B1 (en) | 1999-04-12 | 2002-08-06 | Bioenergy Inc. | Compositions for increasing athletic performance in mammals |
| US6534480B2 (en) | 1999-06-17 | 2003-03-18 | Bioenergy Inc. | Compositions for increasing energy in vivo |
| FR2797767B1 (fr) | 1999-08-27 | 2002-06-14 | Centre Nat Rech Scient | Utilisation d'acides amines pour la fabrication de medicaments destines au traitement des insulino-resistances |
| GB9924650D0 (en) * | 1999-10-19 | 1999-12-22 | Marathade Ltd | Energy bar |
| US6703370B1 (en) | 1999-10-27 | 2004-03-09 | Bioenergy, Inc. | Use of ribose to treat fibromyalgia |
| AU1800801A (en) * | 1999-11-17 | 2001-05-30 | Eric H. Kuhrts | Exercise and muscle enhancement formulations |
| US6399661B1 (en) | 2000-06-26 | 2002-06-04 | Jeffrey M. Golini | Oral creatine supplement and method for making same |
| US20030212134A1 (en) * | 2001-04-16 | 2003-11-13 | Dykstra John C. | Combination of pinitol and creatine to enhance uptake and retention of creatine |
| US20030013767A1 (en) * | 2001-07-13 | 2003-01-16 | Samuel Bessman | Method of treating weight loss using creatine |
| US20040013732A1 (en) * | 2001-09-25 | 2004-01-22 | Michael Farber | Starch-based delivery system for creatine |
| US7067150B2 (en) * | 2002-04-16 | 2006-06-27 | Scepter Holdings, Inc. | Delivery systems for functional ingredients |
| AU2003234146A1 (en) * | 2002-04-22 | 2003-11-03 | Experimental And Applied Sciences, Inc. | Food supplements containing 4-hydroxyisoleucine and creatine |
| EP1591116A4 (de) * | 2003-02-06 | 2008-05-28 | Otsuka Pharma Co Ltd | Inhibitor für perioperative blutzucker-erhöhung |
| US7504118B2 (en) | 2003-04-11 | 2009-03-17 | Fhg Corporation | Dietary supplements containing extracts of cinnamon and methods of using same to enhance creatine transport |
| NZ550929A (en) * | 2004-05-07 | 2009-09-25 | Thermo Formulations Ltd | Nutritional composition for increasing creative uptake in skeletal muscle |
| EP1781334A4 (de) * | 2004-08-25 | 2011-07-06 | Iml Formulations Ltd | Zusammensetzungen und verfahren zur proteinsynthese-aktivierung und deaktivierung katabolischer prozesse in skelettmuskel |
| JP2009527504A (ja) * | 2006-02-23 | 2009-07-30 | イオメディックス スリープ インターナショナル エスアールエル | 良質な睡眠の誘導および維持のための組成物および方法 |
| US8613959B2 (en) * | 2009-02-10 | 2013-12-24 | Fhg Corporation | Dietary supplements containing extracts of Nelumbo and processes of using same |
| US8703719B1 (en) | 2009-05-18 | 2014-04-22 | Bio-Engineered Supplements And Nutrition, Inc. | Method and composition for improved muscle performance |
| WO2017075289A1 (en) | 2015-10-27 | 2017-05-04 | Cytozyme Animal Nutrition, Inc. | Animal nutrition compositions and related methods |
| US10674746B2 (en) | 2015-10-27 | 2020-06-09 | Cytozyme Animal Nutrition, Inc. | Animal nutrition compositions and related methods |
| US10821123B2 (en) | 2016-02-01 | 2020-11-03 | Bioenergy Life Science, Inc. | Use of ribose for treatment of subjects having congestive heart failure |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1240336B (it) * | 1990-03-21 | 1993-12-07 | Setra | Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica |
| GB9215746D0 (en) * | 1992-07-24 | 1992-09-09 | Hultman Eric | A method of increasing creatine supply depot |
-
1995
- 1995-08-25 GB GBGB9517443.9A patent/GB9517443D0/en active Pending
- 1995-12-15 AU AU41856/96A patent/AU4185696A/en not_active Abandoned
- 1995-12-15 ES ES95940388T patent/ES2150020T3/es not_active Expired - Lifetime
- 1995-12-15 WO PCT/GB1995/002933 patent/WO1996018313A1/en active IP Right Grant
- 1995-12-15 DE DE69518008T patent/DE69518008T2/de not_active Expired - Lifetime
- 1995-12-15 AT AT95940388T patent/ATE194462T1/de active
- 1995-12-15 DK DK95940388T patent/DK0798971T3/da active
- 1995-12-15 CA CA002208047A patent/CA2208047C/en not_active Expired - Lifetime
- 1995-12-15 US US08/875,326 patent/US5968900A/en not_active Expired - Lifetime
- 1995-12-15 EP EP95940388A patent/EP0798971B1/de not_active Expired - Lifetime
- 1995-12-15 PT PT95940388T patent/PT798971E/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE194462T1 (de) | 2000-07-15 |
| EP0798971A1 (de) | 1997-10-08 |
| GB9517443D0 (en) | 1995-10-25 |
| EP0798971B1 (de) | 2000-07-12 |
| AU4185696A (en) | 1996-07-03 |
| CA2208047A1 (en) | 1996-06-20 |
| CA2208047C (en) | 2003-07-15 |
| US5968900A (en) | 1999-10-19 |
| PT798971E (pt) | 2000-12-29 |
| DE69518008T2 (de) | 2001-05-17 |
| MX9704388A (es) | 1998-07-31 |
| WO1996018313A1 (en) | 1996-06-20 |
| ES2150020T3 (es) | 2000-11-16 |
| DK0798971T3 (da) | 2000-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69518008D1 (de) | Steigerung der kreatin und glykogen konzentration im muskel | |
| US6645948B2 (en) | Nutritional composition for the treatment of connective tissue | |
| Vinnars et al. | History of parenteral nutrition | |
| DE2556100C2 (de) | ||
| ES2569949T3 (es) | Formulaciones farmacéuticas que comprenden un péptido complejado con una dicetopiperazina | |
| Gonce et al. | Arginine supplementation and its effect on established peritonitis in guinea pigs | |
| BR0109336A (pt) | Medicamento para a prevenção, melhora e/ou tratamento de uma complicação diabética, droga medicinal adequada ou utilizável como o mesmo, método para prevenir, melhorar e/ou tratar a complicação diabética, e a neuropatia, e, usos de um agente redutor do açúcar no sangue pós-prandial e pelo menos um agente selecionado de um agente anti-hipertensivo, um agente vasodilatador e um agente anti-hiperlipidêmico | |
| JPH04352718A (ja) | 動物の肝臓のグリコーゲン貯蔵能力増大用治療剤 | |
| US6660308B1 (en) | Beverage and additive for the ill | |
| KR920000324A (ko) | 필수 지방산 처리법 | |
| KR910019640A (ko) | 클로스트리듐 디피실레 하리증 및 위막성 대장염의 예방 및 치료용 의약조성물 | |
| KR940018089A (ko) | 내부조직의 방사선 손상에 대한 예방 및 처치방법 | |
| KR880005933A (ko) | 비타민 b6-함유 약제학적 제제 | |
| JPH01287041A (ja) | 徐放性製剤 | |
| Waymack et al. | Nutritional support of the burned patient | |
| León et al. | Arginine supplementation improves histone and acute‐phase protein synthesis during gram‐negative sepsis in the rat | |
| US5491150A (en) | Supplementary therpeutic agents for the treatment of immunodeficiency syndrome | |
| Edidin | Cutaneous manifestations of diabetes mellitus in children | |
| KR920702225A (ko) | 약학 조성물 | |
| KR940013503A (ko) | 동맥경화증의 예방 또는 치료용 약제학적 조성물 | |
| EP0459377B1 (de) | Verwendung von Prostaglandin-E1 zur Behandlung männlicher erektiler Impotenz | |
| Drill | Effect of Vitamin B1 and Vitamin B2 Complex on the Loss of Weight Produced in Rats by Experimental Hyperthyroidism | |
| KR900007434A (ko) | 시스타틴을 유효 성분으로하는 치료제 | |
| US6979458B1 (en) | Beverage and additive for wellness | |
| US4650668A (en) | Composition for relieving toothache pain and other forms of intense pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8332 | No legal effect for de | ||
| 8370 | Indication related to discontinuation of the patent is to be deleted | ||
| 8364 | No opposition during term of opposition | ||
| 8327 | Change in the person/name/address of the patent owner |
Owner name: MUSCLETECH RESEARCH AND DEVELOPMENT,INC., MISSISSA |